Advertisement

Topics

Theraclone Sciences, Inc. Company Profile

13:19 EDT 20th March 2019 | BioPortfolio

Theraclone Sciences is a Seattle‐based biotechnology company focused on the development of novel therapeutic antibodies for the treatment of infectious disease and cancer. The company’s technology harnesses the power of the human immune system to identify rare, naturally evolved antibodies from the blood cells of immunologically relevant human subjects. Human monoclonal antibodies can be rapidly isolated using the I‐STAR™ discovery platform and scaled for industrial production. Such human antibody drug candidates may be uniquely safe and relevant to combating disease across broad patient populations. Theraclone is a privately held company with venture investment from ARCH Venture Partners, Canaan Partners, Healthcare Ventures, MPM Capital, Amgen Ventures and Alexandria Real Estate Equities. For additional information, please visit www.theraclone‐sciences.com.


News Articles [601 Associated News Articles listed on BioPortfolio]

Theraclone Sciences Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 16102018] Prices from USD $250

SummaryTheraclone Sciences Inc Theraclone is a biotech company that develops novel therapeutic antibodies for the treatment of cancer and infectious diseases. The company offers development programs o...

Roivant Sciences Raises $200 Million, Bringing its Valuation to $7 Billion

Vivek Ramaswamy’s Roivant Sciences, the umbrella company to 14 Vant companies, including Datavant, Enzyvant Sciences, Urovant Sciences and others, raised another $200 million in equity financing.

National Academy of Sciences honors 18 for major contributions to science

(National Academies of Sciences, Engineering, and Medicine) The National Academy of Sciences will honor 18 individuals with awards in recognition of their extraordinary scientific achievements in a wi...

Almac Sciences: Company Activity and Sharing Risks in Collaborations

In this episode of PharmaTelevision News Review, Fintan Walton talks with Denis Geffroy, Vice President Business Development at Almac Sciences at Almac. Filmed at BioTrinity 2010 in Newbury, UK, they ...

Urovant Sciences nets $130.2mm in Nasdaq IPO

Roivant Sciences GMBH's urology-focused subsidiary Urovant Sciences Ltd. netted $130.2mm in an initial public offering of 10mm shares at $14 apiece (the low end of its $14-16 range).

#Cannabisstocks: ( $CVSI) CV Sciences, Inc.'s PlusCBD Oil featured on Oct. 3rd Episode of ‘The Dr. Oz Show'

October 9, 2018 (Investorideas.com Newswire) CV Sciences, Inc. (CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), preeminent supplier and manufacturer of hemp-derived phytocannabinoids

Alimera Sciences, Inc.: Alimera Sciences Announces Canadian Regulatory Approval for ILUVIEN(R)

ATLANTA, GA / ACCESSWIRE / November 26, 2018 / Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today a...

Gilead Sciences-Aktie sieht attraktiv aus!

Toronto (www.aktiencheck.de) - Gilead Sciences-Aktienanalyse von Analyst Matthew Luchini von BMO Capital Markets: Laut einer Aktienanalyse in Bezug auf den US-Biotechkonzern Gilead Sciences Inc. (I...

Drugs and Medications [45 Associated Drugs and Medications listed on BioPortfolio]

Mondoxyne [oculus innovative sciences]

Mondoxyne NL 50mg

Mondoxyne nl 100mg [oculus innovative sciences]

Monodoxyne NL 100mg

Deltasone [oculus innovative sciences]

Deltasone 20mg prednisone tablets

Complera access [gilead sciences, inc.]

These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA™ (emtricitabine, rilpivirine, tenofovir dis...

Emtriva [gilead sciences, inc.]

These highlights do not include all the information needed to use EMTRIVA safely and effectively. See full prescribing information for EMTRIVA. EMTRIVA (emtricitabine) capsule, for oral use EMTRIVA (e...

Clinical Trials [212 Associated Clinical Trials listed on BioPortfolio]

M-learning to Improve Professional Competencies in Health Sciences

The aim of this study is to investigate whether a mobile application is useful for improving knowledge about professional competencies in students enrolled in Health Sciences degrees.

Cognitive Rehabilitation With C8 Sciences

C8 sciences program is a cognitive training program mainly developed for the students, and the effectiveness is well established. The aim of this trial is to assess clinical efficacy of th...

A Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare, Egypt) & Sovaldi 400 mg F.C.T ( Gilead Sciences, Ireland)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Sofosbuvir from Heterosofir 400 mg F.C.T (Pharmed Healthcare Co., Egypt) versus S...

The Efficiency of CAMS (Chinese Academy of Medical Sciences)-2016 Trial for Pediatric Acute Myeloid Leukemia

The purpose of this study is to evaluate that whether the AML (acute myeloid leukemia)-CAMS (Chinese Academy of Medical Sciences)-2016 regimen, includes risk-stratified therapy and the use...

Dietary Pattern and Metabolic Health Study

This is a single-blind, randomized trial. Based on inclusion and exclusion criteria, 450 eligible volunteers, who were 25-60 years old, with overweight/obese and prediabetes are assigned t...

Companies [1094 Associated Companies listed on BioPortfolio]

Theraclone Sciences, Inc.

Theraclone Sciences is a Seattle‐based biotechnology company focused on the development of novel therapeutic antibodies for the treatment of infectious disease and cancer. Th...

Theraclone Sciences

Theraclone Sciences is a Seattle‐based biotechnology company focused on the development of novel therapeutic antibodies for the treatment of infectious disease and cancer. Th...

Theraclone Sciences and MD Anderson

DVS Sciences, Inc.

DVS Sciences is a life sciences technology company that has developed and manufactures a novel technology for highly multiplexed analysis of single cells. DVS Sciences has an R&D ...

Origin Sciences Limited

Origin Sciences is a medical technology company developing innovative devices and tests to aid the detection and diagnosis of gastrointestinal diseases. Origin Sciences is based i...

More Information about "Theraclone Sciences, Inc." on BioPortfolio

We have published hundreds of Theraclone Sciences, Inc. news stories on BioPortfolio along with dozens of Theraclone Sciences, Inc. Clinical Trials and PubMed Articles about Theraclone Sciences, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Theraclone Sciences, Inc. Companies in our database. You can also find out about relevant Theraclone Sciences, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record